Загрузка...
Adjuvant BCG immunotherapy for malignant melanoma.
A total of 199 patients with stage I malignant melanoma at Clark's level 3 to 5 of invasion were entered into a prospectively controlled randomized clinical trial that attempted to assess the value of local and systemic immunotherapy with BCG (bacille Calmette-Guérin) after surgery. The patient...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
1984
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1483595/ https://ncbi.nlm.nih.gov/pubmed/6383591 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|